Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Biomarkers
Banyan Biomarkers Inc

Organization & Developments: Banyan Biomarkers

Parents

*BANYAN BTI
2018: FDA OKs First Blood-Based Concussion Detection Test
2018: First Blood Test to Detect Concussions Receives FDA Approval
Banyan Biomarkers, Inc. is focused on developing a simple point-of-care blood test that could be used by physicians to rapidly detect the presence of mild and moderate brain trauma and improve the medical management of head injured patients.
Blood Based Therapy for Traumatic Brain Injury (TBI)
ELISAs for TBI biomarkers
The Company’s test uses two protein biomarkers licensed from the McKnight Brain Institute at the University of Florida that rapidly appear in systemic circulation after a brain injury.